Mellanox Technologies, Asset Acceptance Capital, Bank of America, Infosys, Credit Suisse Group, Pluristem Therapeutics, Yum! Brands, Deutsche Bank and Perrigo Co are among the companies whose shares are moving in pre-market trading Thursday.
Mellanox Technologies, Ltd. (MLNX) stock climbed 37.42 percent to $91.22 in pre-market trading after reporting a sharp increase in second quarter earnings. Its second quarter net profit surged to 32.09 million or $0.74 per share from $2.13 million or $0.06 per share in the same period a year-ago. The company's revenue more than doubled to $133.47 million from 63.35 million in the same quarter last year and also beat analysts' estimation of $128.34 million.
Asset Acceptance Capital Corp. (AACC) stock climbed 11.35 percent to $7.75 in pre-market trading. The stock has a 52-week low of $2.80, a 52-week high of $8.16 and $213.80 million in market capitalization.
Bank of America Corp. (BAC) stock gained 1.06 percent to $7.61 in pre-market trading. The New York financial giant reported second quarter earnings Wednesday. BAC swung to second quarter net profit of $2.46 billion or $0.19 per share compared to the net loss of $8.83 billion or $0.90 per share in the same quarter a year ago and also topped Reuters' estimate of $0.14 per share. Revenue surged to $21.97 billion from $13.24 billion last year.
Infosys Ltd. (INFY) stock advanced 1.57 percent to $40.42 in pre-market trading. The stock has a 52-week low of $38.12, a 52-week high of $64.00 and $22.74 billion in market capitalization.
Credit Suisse Group AG (CS) stock plunged 3.49 percent to $17.71 in pre-market trading. The stock has a 52-week low of $16.95, a 52-week high of $37.99 and $22.47 billion in market capitalization.
Pluristem Therapeutics Inc. (PSTI) stock plunged 3.35 percent to $2.60 in pre-market trading. The company stock climbed nearly 10 percent in regular trading Wednesday after announcing a collaborative agreement with CPC Clinical Research (CPC) to manage PSTI's upcoming Phase II clinical trial for its proprietary stem-cell therapy in the treatment of peripheral artery disease.
Yum! Brands, Inc. (YUM) stock declined 2.36 percent to $64.00 in pre-market trading as its second quarter profit fell short of expectations. Net income was $331 million or $0.69 per share, up from $316 million or $0.65 per share in the same period last year but fell short of analysts' estimation of $0.70 per share.
Deutsche Bank AG (DB) stock declined 1.21 percent to $31.15 in pre-market trading. The bank is planning to cut 1,000 investment banking jobs in response to tough conditions in capital markets, according to Reuters.
Perrigo Co. (PRGO) stock fell 1.26 percent to $113.28 in pre-market trading. The stock has a 52-week low of $75.89, a 52-week high of $119.29 and $10.27 billion in market capitalization.